{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:22:10Z","timestamp":1789046530590,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background\/Objectives: Patients with type 2 diabetes mellitus (T2DM) frequently develop diffuse and anatomically complex coronary artery disease (CAD), resulting in a substantially increased cardiovascular risk. Although both HDL-C and the triglyceride-to-high-density lipoprotein cholesterol (TG\/HDL-C) ratio have been associated with cardiovascular risk, their relative associations with and discriminatory performance for angiographic CAD complexity remain uncertain. This study aimed to evaluate and compare these two lipid parameters in relation to CAD complexity as assessed by the SYNTAX score. Methods: A retrospective, observational, single-center study was conducted involving 167 consecutive T2DM patients who underwent diagnostic coronary angiography. CAD complexity was quantified using the SYNTAX score, with patients categorized into low (\u226422) and higher (&gt;22) complexity groups. Statistical evaluation included correlation analyses, univariable and multivariable logistic regression, and receiver operating characteristic (ROC) curve analysis. Results: Of the 167 patients, 48 (28.7%) were classified with higher SYNTAX scores. HDL-C showed a significant inverse correlation with the SYNTAX score (r = \u22120.339, p &lt; 0.001), whereas the TG\/HDL-C ratio showed a weak positive correlation (r = 0.159, p = 0.040). In separate multivariable models adjusted for sex, both HDL-C (OR 0.944, 95% CI 0.908\u20130.980; p = 0.003) and the TG\/HDL-C ratio (OR 1.085, 95% CI 1.003\u20131.175; p = 0.041) remained associated with a higher SYNTAX score. HDL-C showed a numerically higher AUC than the TG\/HDL-C ratio (0.659 vs. 0.621); however, the difference between the AUCs was not statistically significant (DeLong p = 0.268). Conclusions: Lower HDL-C and a higher TG\/HDL-C ratio remained associated with a higher SYNTAX score after adjustment for sex. Although HDL-C showed numerically better discrimination, no statistically significant difference in discriminatory performance was demonstrated between the two markers.<\/jats:p>","DOI":"10.3390\/jcm15166400","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:30:53Z","timestamp":1787131853000},"page":"6400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HDL Cholesterol and the Triglyceride-to-HDL Cholesterol Ratio in Relation to Coronary Artery Disease Complexity in Patients with Type 2 Diabetes Mellitus"],"prefix":"10.3390","volume":"15","author":[{"given":"Mehmet","family":"Aydo\u011fan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-7518","authenticated-orcid":false,"given":"Mustafa L\u00fctfi","family":"Yavuz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8686-2645","authenticated-orcid":false,"given":"Emre","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1085-5462","authenticated-orcid":false,"given":"Pelin","family":"Karaca \u00d6zer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-4335","authenticated-orcid":false,"given":"Samim","family":"Emet","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istanbul Faculty of Medicine, Istanbul University, 34093 Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jdi.14042","article-title":"Updates on dyslipidemia in patients with diabetes","volume":"14","author":"Ide","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.5114\/aoms\/216960","article-title":"2025: The year in cardiovascular disease\u2014The year of triglyceride-lowering therapies","volume":"21","author":"Toth","year":"2025","journal-title":"Arch. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: A multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, P., Cai, J., Yuan, S., Li, Y., Shi, H., Liang, C., He, B., Xie, Q., Lei, B., and Bai, J. (2025). The relationship between triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular risk. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1688624"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.25122\/jml-2024-0117","article-title":"Triglyceride\/high-density cholesterol ratio as a predictor of cardiometabolic risk in young population","volume":"17","year":"2024","journal-title":"J. Med. Life"},{"key":"ref_8","first-page":"219","article-title":"The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes-2025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"World Medical Association (2025). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human participants. JAMA, 333, 71\u201374.","DOI":"10.1001\/jama.2024.21972"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/89.5.815","article-title":"Selective coronary arteriography. I. A percutaneous transfemoral technic","volume":"89","author":"Judkins","year":"1967","journal-title":"Radiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref_17","first-page":"49","article-title":"Influence of high-density lipoprotein cholesterol and rheological factors on the sex difference in cardiovascular disease","volume":"7","author":"Price","year":"2000","journal-title":"J. Cardiovasc. Risk"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","article-title":"Diabetes as risk factor for incident coronary heart disease in women compared with men: A systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events","volume":"57","author":"Peters","year":"2014","journal-title":"Diabetologia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-2275(20)40067-7","article-title":"Turkish Heart Study: Lipids, lipoproteins, and apolipoproteins","volume":"36","author":"Mahley","year":"1995","journal-title":"J. Lipid Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.numecd.2021.11.005","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in the general population: A systematic review and meta-analysis of cohort studies","volume":"32","author":"Chen","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1590\/S1807-59322008000400003","article-title":"High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease","volume":"63","author":"Favarato","year":"2008","journal-title":"Clinics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jacl.2021.07.005","article-title":"Reference values for the triglyceride to high-density lipoprotein ratio and its association with cardiometabolic diseases in a mixed adult population: The ELSA-Brasil study","volume":"15","author":"Lelis","year":"2021","journal-title":"J. Clin. Lipidol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12944-019-1098-0","article-title":"Comparison of discrimination for cardio-metabolic risk by different cut-off values of the ratio of triglycerides to HDL cholesterol","volume":"18","author":"Wakabayashi","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am. J. Med."},{"key":"ref_25","first-page":"5A","article-title":"Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study","volume":"4","author":"Castelli","year":"1988","journal-title":"Can. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"(2009). Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 302, 1993\u20132000.","DOI":"10.1001\/jama.2009.1619"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Aim-High Investigators (2011). Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med., 365, 2255\u20132267. Correction in N. Engl. J. Med.\u00a02012, 367, 189.","DOI":"10.1056\/NEJMoa1107579"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"HPS2-THRIVE Collaborative Group (2014). Effects of extended-release niacin with laropiprant in high-risk patients. N. Engl. J. Med., 371, 203\u2013212.","DOI":"10.1056\/NEJMoa1300955"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","article-title":"HDL and cardiovascular disease","volume":"384","author":"Rader","year":"2014","journal-title":"Lancet"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:46:52Z","timestamp":1787132812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":30,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166400"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166400","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]}}}